Zum Inhalt

Insights into the utilisation of 1,2-propanediol and interactions with the cell envelope of Clostridium perfringens

  • Open Access
  • 01.12.2025
  • Research
Erschienen in:

Abstract

Background

Breastfeeding is a major determinant of gut microbiota composition and fermentation activity during the first months of life. Breastmilk delivers human milk oligosaccharides (HMO) as substrates for microbial intestinal fermentation. One of the main metabolites that accumulates in feces of breastfed infants is 1,2-propanediol (1,2PD) resulting from the metabolism of fucosylated HMO. 1,2PD is used in microbial cross-feeding to produce propionate, but 1,2PD is also an alcohol that can impact the state of the microbial cell envelope. To shed further light on an understudied compound in the infant gut, we investigated the genetic and metabolic potential of the early gut colonizer Clostridium perfringens to utilise 1,2PD, and the interactions of 1,2PD with the cell envelope.

Results

Based on genome analysis, C. perfringens FMT 1006 isolated from infant feces possessed most genes of the pdu operon related to 1,2PD metabolism. C. perfringens consumed 1,2PD (78%) and produced 1-propanol as the main metabolite, while propionate was not detected. In agreement, genes responsible for 1,2PD utilisation and propanol formation (pduCDE, dhaT) were highly expressed. When cultivated in the presence of 1,2PD and glucose, a higher proportion of 1,2PD carbon (87%) was recovered as compared to incubation with only 1,2PD (34%). At the same time, lactate and acetate were formed in a ratio of 2.16:1.0 with 1,2PD and glucose compared to a ratio 9.0:1.0 during growth with only glucose possibly due to reallocation of the NAD+/NADH pool in favor of 1-propanol formation. The presence of 1,2PD slightly increased membrane fluidity and modified the composition of the membrane to a higher content of elongated glycerophosphoethanolamines.

Conclusion

We provide here new knowledge on the metabolism of 1,2PD by a microbial species that is present during breastfeeding and observed that C. perfringens metabolised 1,2PD mainly to propanol. The presence of 1,2PD had little impact on membrane fluidity and let to modifications of membrane lipid composition. Collectively, these findings advance our understanding of on intestinal metabolite-microbe interactions during breastfeeding.

Supplementary information

The online version contains supplementary material available at https://doi.org/10.1186/s13099-025-00689-1.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

The human gastrointestinal ecosystem plays a crucial role in maintaining homeostasis and influences host health. Infants experience dynamic shifts in gut microbiota composition that are influenced by various factors including mode of birth delivery, antibiotic exposure, and diet [1]. During breastfeeding, the infant gut microbiota is exposed to various macromolecules present in human milk. Human milk oligosaccharides (HMOs) are complex and abundant carbohydrates that serve as prebiotics promoting the growth of beneficial bacteria such as Bifidobacterium spp. [2]. Fucosyllactose (FL) represents 90% of the HMOs in breast milk [2]. Digestion of 2-FL and 3-FL by fucosidase activity of Bifidobacterium spp. releases the monosaccharides glucose, galactose and fucose [35], which can be further metabolised to acetate, lactate, formate and 1,2-propanediol (1,2PD) through fermentation. In particular, lactate and 1,2PD accumulate in infant feces during breastfeeding in the early months of life [2] and median fecal levels of 1,2PD ranged from 5.4-14.5 mM at 3 months of age [2, 6]. 1,2PD can be metabolised to 1-propanol and the short chain fatty acid (SCFA) propionate [5]. Additionally, 1,2PD is an alcohol with the potential to inhibit microbial growth. Thus, it is crucial to understand the impact 1,2PD accumulation on the microbial community during the breastfeeding phase.
Utilisation of 1,2PD is catalysed by enzymes encoded by the pdu operon. The signature enzyme is PduCDE, a diol/glycerol dehydratase (Fig. 1), which requires the formation of bacterial microcompartment (BMC) to protect the intracellular space from the toxic intermediate propanal [79]. Propanal is catabolise to propionyl-CoA by PduP and to 1-propanol by PduQ. Transformation of propionyl-CoA by PduW yields propionateand generates ATP.
Fig. 1
Genome arrangement of the pdu cluster in Clostridium perfringens FMT 1006 and other strains. The genome of FMT 1006 was sequenced by Oxford Nanopore Technologies and Illumina MiSeq and annotated with Prokka (annotated genes in black) with refinements using InterProScan (indicated with *). Identity of certain proteins (light blue) was additionally confirmed by BLASTp analysis. Genes were detected on three gene clusters, clustereut, pdu (clusterpdu) and clusterpduW. Gray arrows indicate missing genes
Bild vergrößern
1,2PD utilisation has been reported for enteropathogens such as Listeria monocytogenes and Salmonella enterica Serovar Typhimurium, and the ability to utilise 1,2PD has been linked to pathogenicity [79]. In the adult human gastrointestinal tract, few commensals are capable of utilising 1,2PD such as Anaerobutyricum hallii, Blautia obeum, and Ruminococcus gnavus [10]. During breastfeeding, these taxa only occur at low abundance in infant feces [11], at the same time, fecal propionate levels are low [12] despite the availability of 1,2PD for cross-feeding.
Clostridium perfringens is among the early gut colonizers with potential for PduCDE activity [2]. Strains of the species C. perfringens are potential toxin-carrying opportunistic pathogens, and strains can cause diseases ranging from mild gastrointestinal disturbances to life-threatening infections for example necrotizing enteritis in preterm infants, and gas gangrene [13, 14]. Yet, C. perfringens has been frequently detected in feces of healthy infants [2, 15, 16] and was suggested as a contributor to early butyrate production [11]. Whether the potential to use 1,2PD contributes to the occurrence of C. perfringens in the infant gut environment is not known.
It was the aim of this study to investigate the impact of 1,2PD on the metabolism and cell envelope of C. perfringens in more detail. Through a combination of genome analysis, metabolic profiling, and gene expression studies, we demonstrate that C. perfringens converted 1,2PD primarily to 1-propanol and that 1,2PD conversion was higher when glucose was available. The presence of the alcohol 1,2PD increased membrane fluidity and altered composition of some membrane lipids indicating that 1,2PD exerted a plethora of effects on C. perfringens.

Results and discussion

Genome characterisation and identification of pdu cluster

C. perfringens is a frequent inhabitant of the infant gut especially during the breastfeeding phase [11], yet few isolates have been characterised in detail. C. perfringens FMT 1006 has been isolated from infant feces [17]. To determine the genetic potential of FMT 1006, we isolated DNA and performed genome analysis combining nanopore (Oxford Nanopore Technologies) and MiSeq sequencing (Illumina). The genome was compared to other strains with closed genomes that were obtained from animals, food and the environment (Table 1). Genomes with ANI values above 95% are considered as the same species [18]. Based on our analysis using EDGAR 3.0 [19], the C. perfringens strains used in this study were closely related (ANI 96–99%) (Fig. S1). The pangenome encompassed 4117 genes, while the core genome consisted of 2033 genes. There were 982 singletons, and 1100 dispensable genes present in a subset of the strains.
Table 1
Genome characteristics of C. perfringens FMT 1006 (PRJEB79013) and of strains from different isolation sources. CDS: coding regions. ATCC 13,124 (GCA_000013285); Str. 13 (GCA_000009685.1); SM101 (GCA_000013845); JP55 (GCA_001579765.1); FORC_003 (GCA_001304735.1); NCTC 2837 (GCA_900478015.1). Genome assembled were obtained from NCBI, annotations were performed following the same pipeline as for FMT 1006
 
C. perfringens strain
FMT 1006
ATCC 13124
str. 13
SM101
JP55
FORC_003
NCTC 2837
Accession number
PRJEB79013
GCA_000013285
GCA_000009685.1
GCA_000013845
GCA_001579765.1
GCA_001304735.1
GCA_900478015.1
Origin
Infant feces
Bovine
Soil isolate
Boiled salt beef and beans
Equine
Aquarium water
Unknown
Genome size (Mbp)
3.2
3.3
3.1
3.0
3.6
3.4
3.3
GC content (%)
28.5
28.5
28.5
28.2
28.2
28.4
28.4
Number of contigs
1
1
2
1
6
2
1
Protein-coding genes
2774
2876
2659
2578
3234
2928
2887
rRNA
30
23
30
30
30
30
30
tRNA genes
94
93
96
94
95
96
96
N50 (Mbp)
3.2
3.3
3.0
2.9
3.3
3.3
3.3
Completeness (%)
99.4
97.9
97.33
99.89
100
99.99
99.99
Contamination (%)
0.00
0.95
0.43
0.5
0.13
1.82
0.06
Coverage fold (x)
99
 
9.1
9.4
100
207
258
Alpha toxin
+
+
+
+
+
+
+
Reference
This article
[13]
[65]
[13]
[66]
Not published
[67]
The genome of FMT 1006 had a size of 3.2 Mbp and a GC content of 28.5% similar to the other strains (3.0-3.6 Mbp) (Table 1). FMT 1006 harboured 2774 coding DNA sequences (CDS) and a total of 124 RNA components (Table 1). FMT 1006 possessed a total of 100 unique CDS compared to the other six strains (Fig S1A). KEGG identified 1544 proteins with e-value cut-off of 0.01. All genomes possessed the plc gene encoding the alpha toxin Plc (phospholipase C).
Annotations of all genomes were performed with Prokka and refined with InterProScan [20, 21], which confirmed the presence of pduCDE genes (also sometimes annotated as dhaB) in C. perfringens FMT 1006 and the other strains encoding the three subunits of glycerol/diol dehydratases (Fig. 1). pduCDE (T_01016-T_01018) and dhaT (T_01024), encoding the 1,3-propanediol oxidoreductase (DhaT), which has been shown previously to perform alcohol dehydrogenase (PduQ) activity [22], were located in cluster with genes related to cobalamin turnover pduGH (T_01019-T_01020) and pduO (T_01021) (clusterpdu). Other potential pdu related genes such as pduL (T_00814), pduU (T_00802) and pduV (T_00803) were found within a gene cluster that mainly contained genes related to ethanolamine utilisation (Fig. 1) (clustereut). The gene encoding protein AdhE_1 (T_00801) that was identified as PduQ by InterProScan, was in proximity to pduU and pduV (Fig. 1). A candidate gene pduW (T_01799) was located at a different location on the genome (clusterpduW). When characterised with additional BLASTp analysis, PduW was 100% identical to PduW of other C. perfringens strains, and had 71% identity with PduW from Clostridium baratii (Suppl. Table 1).
We conducted additional BLASTp (v. 2.11.0+) analysis using previously functionally characterised PduP of Salmonella (AAD39015.1) [23] to identify possible homologues of PduP. No homologue of PduP was present in the genome of C. perfringens, the closest hits were AdhE_2 (T_00811) with 29% identity and another acetaldehyde dehydrogenase (T_02661) with 31% identity. Taken together, theoretical homologues of enzymes related to 1,2PD utilisation were identified with identity values above > 40% except for PduP (Suppl. Table 1).
Similar to FMT 1006, the genomes of the other assessed C. perfringens strains possessed most pdu genes except pduP conferring the overall potential of utilizing 1,2PD (Fig. 1). Genes were located on two clusters with the exception of pduW (T_01799), and gene syntety of pdu and eut was conserved except for SM101, which lacked the eut cluster (Fig. 1). In Limosilactobacillus reuteri, Salmonella or Listeria, the pdu genes were encoded in one operon that also included genes related to cobalamin synthesis and to ethanolamine utilisation [2426] (Fig. 1). The pdu operon of Propionibacterium freudenreichii DSM 20271 was organised similar to C. perfringens with pdu present in two different loci [7] indicating that organisation of pdu differs between species.

1-propanol is the major compound produced from 1,2PD

As C. perfringens FMT 1006 possessed the general ability for 1,2PD utilisation based on its genome sequence but lacked a gene encoding PduP, which catalyses the formation of propionate, we evaluated the growth and fermentative activity in anaerobically prepared yeast extract casitone (YC) medium supplied with 50 mM glucose (YC-G50), 50 mM of 1,2PD (YC-PD50) or without additional carbon source (YC) at 37 °C for 24 h in serum flasks. The concentration of 1,2PD was chosen to reflect concentration ranges in feces [2, 6]. We measured optical density (OD600) and determined substrate utilisation and metabolite formation with high performance liquid chromatography with refractive index detector (HPLC-RI).
In YC-G50, C. perfringens reached highest density (1.98 OD600) at 24 h (Fig. 2A). At 6 h, C. perfringens had a growth rate of 0.28 OD600/h and a doubling time of 2.44 h in YC-G50. C. perfringens reached similar OD600 values at 24 h when incubated in YC and in YC-PD50 (0.30 and 0.25 OD600, respectively) (Fig. 2A). Low optical density was also observed when A. hallii, B. obeum, L. reuteri or R. gnavus were grown in a similar medium with 1,2PD as added carbon source [10] suggesting that 1,2PD metabolism did not contribute to biomass formation.
Fig. 2
Turbidity, substrate utilisation and metabolite formation of C. perfringens FMT 1006. C. perfringens was incubated in YC-G50 (50 mM glucose) and YC-PD50 (50 mM 1,2PD) or in YC in 30 mL serum flasks for 24 h anaerobically at 37 °C, OD600 was monitored, and substrate utilisation and metabolite formation were analysed by HPLC-RI. (A) OD600, (B) glucose utilisation, (C) 1,2PD utilisation, and (D) lactate, (E) 1-propanol, (F) acetate, (G) propanal, (H) butyrate, and (I) propionate formation in. Each time point is an average of n = 2–7 biological replicates
Bild vergrößern
Fermentative activity of C. perfringens was the highest in YC-G50. After 24 h, 42.5 ± 5.4 mM lactate was formed from 24 ± 0.9 mM glucose, followed by 6.8 ± 1.2 mM butyrate and 3.3 ± 1.6 mM acetate (Fig. 2B, D, E and F). In YC-PD50, 33.3 ± 5.8 mM 1,2PD (78.6%) were consumed and converted to 7.3 ± 0.2 mM 1-propanol and 1.8 ± 0.2 mM propanal without detectable levels of propionate (Fig. 2C, G, H and I). Propanal is a toxic compound and to prevent intracellular damage, BMC are formed during the utilisation of 1,2PD [27]. Acetate, lactate, butyrate, were present in low amounts (below 2 mM) (Fig. 2D, E and F). 1,2PD, 1-propanol, propanal or propionate were not detected when C. perfringens was incubated in YC (Fig. 2C, G, H and I). When A. hallii was tested at similar conditions, the carbon provided in form of 1,2PD was fully recovered as propanol, propanal and propionate (C1,2PD used=Cpropanol+Cpropanal+Cpropionate) [28], while in this study, the proportion was only approx. 34% (C1,2PD used > Cpropanol+Cpropanal).
As we could not recover the expected metabolites from the liquid phase, we examined levels of 1-propanol, propanal and other potential metabolites in the headspace using proton-transfer-reaction mass spectrometry (PTR-TOF-MS) and estimated the concentrations in liquid media according to Henry’s law assuming air-water equilibrium. The detection of 1-propanol and propanal was confirmed by gas chromatography-MS (GC-MS). Smaller amounts of 2-ethyl-2-butenal and 2-methyl-pentanal were detected by both PTR-MS and GC/MS. Propanal levels were estimated 4.4-times higher based on headspace measurement than levels determined with HPLC-RI, and estimates for 1-propanol were 1.6-fold higher (Suppl. Table S2). The carbon C1,2PD that could be recovered as Cpropanol+Cpropanal was approx. 60%. As we observed a peak in HPLC-RI profiles at the retention time of 1,3-propanediol (1,3PD), we suggest that additional aldehyde hydration events occur in the liquid medium, which might account for the discrepancy between measured and estimated levels.
Taken together, our data show that C. perfringens metabolised 1,2PD to 1-propanol with a C1,2PD recovery of 33–60% depending on analysis of compounds present in the liquid broth or the headspace.

Gene expression profiles support observation of 1,2PD being mainly utilised to 1-propanol

Based on cultivation studies and genome characterisation, C. perfringens FMT 1006 did not form propionate when incubated in YC-PD50 and did not possess any genes related to propionate formation via PduP. We next determined gene expression profiles of C. perfringens when grown in YC-G50, YC-PD50 and YC. RNA was collected during the exponential phase of growth in YC-G50, while samples for RNA profiling of YC and YC-PD50 were obtained when the OD600 increased after 3 and 4 h incubation, respectively. Custom gene expression microarrays were synthesised using maskless DNA photolithography [2931] and were hybridised using RNA transcribed to fluorescently labelled cDNA.
In YC-PD50, genes of the pdu cluster, i.e. pduCDE, pduGH, pduO, dhaG and dhaT had higher fluorescence signal (p < 0.05) compared with YC-G50 or YC (Table 2). At the same time, genes of the eut clustereut (eutA, eutB, eutM and pduL) had a lower signal (p < 0.05) in YC-PD50 compared to YC or YC-G50 (Table 2). pduW was not differently expressed. In YC-G50, genes related to glucose utilisation (acetyl-coA transferase thlA, L-lactate dehydrogenase ldh) or electron transfer (e.g. flavodoxin T_00556 or NADH oxidoreductase T_00907) were significantly (p < 0.05) upregulated compared to YC-PD50 (Table 2).
Table 2
Differential expression of selected genes of C. perfringens dependent on culture conditions. RNA isolated from C. perfringens FMT 1006 after 3–4 h culture in YC, YC-G50 and YC-PD50. RNA transcribed to cDNA labelled fluorescently and used in microarray hybridization. Log fold expression (LogFC) was calculated from fluorescence intensities at the tested conditions. * Indicates significancy (p < 0.05) with Wald’s test. n.s: not significant
genes of interest
locus_tag
YC vs. YC-PD50
YC-G50 vs. YC-PD50
logFC
adj. p. value
Change in expression level
logFC
adj. p. value
Change in expression level
adhE_1
T_00801
-0.8 to -0.1
n.s
No change
-0.5 to 0.8
n.s
No change
pduU
T_00802
-1.9 to 0.3
0.00*
Up in YC
-1.2 to 0.5
n.s
No change
pduV
T_00803
-0.8 to 0.7
n.s
No change
0.4 to 1.0
n.s
No change
pdtaR
T_00804
-0.5 to 0.8
n.s
No change
0.1 to 1.5
0.053
Up in YC-PD50
pdtaS
T_00805
-0.5 to -0.1
n.s
No change
-0.2 to 0.2
n.s
No change
eutA
T_00806
-2.7 to -0.4
0.00*
Up in YC
-0.7 to -1.1
0.06
Up in YC-G50
eutB
T_00807
-2.0 to 0.1
0.01*
Up in YC
-0.2 to 0.7
n.s
No change
eutC
T_00808
0.0 to 0.4
n.s
No change
0.0 to 1.1
n.s
No change
eutL
T_00809
-0.7 to 0.2
n.s
No change
-0.4 to 0.2
n.s
No change
eutM
T_00810
-1.4 to 0.2
0.03*
Up in YC
-0.1 to 0.3
n.s
No change
adhE_2
T_00811
0.3 to -0.4
n.s
No change
-0.4 to -0.1
n.s
No change
eutM/pduA
T_00812
0.2 to 0.3
n.s
No change
-0.7 to 0-0.3
n.s
No change
pduO
T_00813
-0.5 to 0.5
n.s
No change
-0.5 to 0.5
n.s
No change
pduL
T_00814
-1.5 to -0.6
0.01*
Up in YC
0.5 to -0.1
n.s
No change
pduM
T_00815
-0.9 to 0.2
n.s
No change
-0.5 to 0.2
n.s
No change
eutN/ccmL
T_00816
-1.2
n.s
No change
-0.7
n.s
No change
pduT
T_00817
-0.7 to -0.1
n.s
No change
-0.6 to 0.5
n.s
No change
eutH_2
T_00818
-0.9 to -0.1
n.s
No change
-1.2 to -0.2
n.s
No change
eutQ
T_00819
-0.8 to -0.2
n.s
No change
-0.9 to -0.3
n.s
No change
glpF_1
T_01014
0.5 to 1.4
0.03*
Up in YC-PD50
-0.1 to 0.2
n.s
No change
pcoR
T_01015
-0.8 to 1.2
n.s
No change
-1.6 to 0.6
n.s
No change
araC
T_01016
-0.1 to 0.6
n.s
No change
-0.5 to -0.3
n.s
No change
pduC
T_01017
0.3 to 1.4
0.057
Up in YC-PD50
1.1 to 0.1
n.s
No change
pduD
T_01018
1.6 to 2.9
0.01*
Up in YC-PD50
1.3 to 0.5
n.s
No change
pduE
T_01019
1.1 to 2.3
0.00*
Up in YC-PD50
0.5 to 1.0
n.s
No change
pduG
T_01020
0.4 to 2.9
0.01*
Up in YC-PD50
1.0 to 1.2
0.053
Up in YC-PD50
pduH
T_01021
-0.5 to 1.6
0.046*
Up in YC-PD50
-0.7 to 0.2
n.s
No change
pduO
T_01022
1.4 to 3.4
0.02*
Up in YC-PD50
0.7 to 1.7
0.085
Up in YC-PD50
dhaG
T_01023
1.8 to 1.9
0.00*
Up in YC-PD50
0.4 to 1.3
0.058
Up in YC-PD50
dhaT
T_01024
1.6 to 2.4
0.00*
Up in YC-PD50
1.8 to 0.5
0.05
Up in YC-PD50
plsX
T_01796
-0.9 to 0.0
n.s
No change
-0.8 to -0.5
n.s
No change
rpmF
T_01797
-0.2 to -0.1
n.s
No change
0.1 to 0.5
n.s
No change
yceD
T_01798
-0.3 to 0.6
n.s
No change
-0.3 to 0.5
n.s
No change
ackA_2 (pduW)
T_01799
-1.3 to -0.1
n.s
No change
-1.2 to 0.4
n.s
No change
pta
T_01800
-1.7 to -0.1
n.s
No change
-2.1 to -0.4
n.s
No change
ldh
T_00063
-0.5 to 0.4
n.s
No change
-1.4
0.00*
Up in YC-G50
flavodoxin
T_00556
-1.6 to 0.6
n.s
No change
-3.3 to -3
0.00*
Up in YC-G50
NADH(P) oxidoreductase
T_00907
-0.6
n.s
No change
-1.4
0.03*
Up in YC-G50
thlA
T_02278
-0.2 to 0.8
n.s
No change
-3.1 to -2.5
0.00*
Up in YC-G50
We conducted additional quantitative PCR (qPCR) analysis to determine expression levels of pduC, pduD, dhaT and pduL relative to housekeeping genes ftsZ, recA and gyrA. In agreement with microarray analysis, pduC, pduD and dhaT were 0.06–0.09 fold downregulated in YC relative to YC-G50, while the same genes were upregulated 2.7–5.6 fold in YC-PD50 relative to YC-G50 (Table 3). pduL was 2.6-fold higher expressed in YC relatively to YC-G50 (Table 3).
Table 3
Relative expression of selected pdu genes. RNA isolated from C. perfringens FMT 1006 after 3–4 h cultivation in YC, YC-G50 and YC-PD50. cDNA was prepared from RNA and gene expression was determined by qPCR using cDNA as template. For standardisation, expression of target genes was calculated relative to the geometric mean of housekeeping genes ftsZ, gyrA and recA, and to expression in YC-G50. RNA was collected from two independent experiments, and each sample was analysed in technical duplicates
Targeted genes expression relative to housekeeping genes relative to expression in YC-G
Medium / gene
pduC
pduD
dhaT
pduL
YC
0.09 ± 0.02
0.06 ± 0.03
0.07 ± 0.01
2.61 ± 0.75
YC-G50
1.00 ± 0.44
1.04 ± 0.54
1.02 ± 0.70
1.02 ± 0.42
YC-PD50
2.75 ± 0.02
5.32 ± 0.02
2.72 ± 0.26
1.25 ± 0.26

The impact of glucose on 1,2PD metabolism

As we observed that the addition of 1,2PD did not support growth of FMT 1006 and that the intermediate propanal was detected after 24 h of incubation, we determined if glucose addition improved biomass formation and the metabolism of 1,2PD when supplied at different concentrations. We combined glucose and 1,2PD at equimolar concentrations (YC-PD10-G10 and YC-PD50-G50) and compared to YC-PD50. FMT 1006 was cultured for 24 h at 37 °C, and turbidity was determined using a McFarland densitometer. HPLC-RI was used to determine substrate utilisation and metabolite formation.
Final turbidity was low in YC-PD10-G10 (1.9 ± 1.4 McFarland units, MF), YC (1 ± 0.4 MF), YC-PD10 (0.7 ± 0.2 MF) and YC-PD50 (1.4 ± 1 MF). When glucose was supplemented to YC-PD50 (YC-PD50-G50, 9 ± 1 MF), turbidity was similar to YC-G50 (10.7 ± 0.6 MF) (Fig. 3A). Compared to cultivation in YC-G50, the presence of 50 mM 1,2PD (YC-PD50-G50) shifted the ratio of acetate:lactate from 1.0:9.0 to 1.0:2.6 (Fig. 3B). Low concentrations of 1,2PD (YC-PD10) led to higher yields of propanal from 1,2PD (60.2% mMpropanal/mM1,2PD) compared to YC-PD50 (8.3% mMpropanal/mM1,2PD). In contrast, the proportion of 1-propanol was similar in YC-PD10 and YC-PD50 (21.0% mMpropanol/mM1,2PD) (Fig. 3C). When glucose was present, the proportion of propanal and 1-propanol was 12% and 88% and 27.1 and 70.1% in YC-PD10-G10 and YC-PD50-G50, respectively (Fig. 3C).
Fig. 3
Impact of glucose on 1, 2PD metabolism of C. perfringens FMT 1006. C. perfringens was cultured in YC-G50, YC, YC-PD10, YC-PD10-G10, YC-PD50, YC-PD50-G50) (A, B,C) or in YC-G50 with addition of 1,2PD at 3, 6, and 12 h (D, E, F) for 24 h at 37 °C. Density was monitored using McFarland densitometer (MF) and substrate utilisation and metabolite formation was recorded with HPLC-RI. (A, D) Turbidity measurements in McFarland units (MF). Significant difference between turbidity values was determined by Dunn’s Test adjusted by Holm. A p < 0.05 was considered significant and was indicated with different letters, (B, E) Utilisation of glucose and formation of acetate, lactate and butyrate. (C, F) 1,2PD utilisation and formation of 1-propanol and propanal. Shown are average values from from biological triplicates and standard deviations
Bild vergrößern
Taken together, we observed that propanal production did not impact final turbidity (p > 0.05) when glucose was provided together with 1,2PD even at 50 mM, suggesting that the low biomass observed in the absence of glucose may not be due to propanal production. Within the Pdu pathway, conversion of propanal by PduQ and PduP requires NAD+/NADH as co-factors (Fig. 4). PduQ uses NADH as electron donor, while PduP employs NAD+ as electron acceptor [32, 33]. In previous studies, Salmonella formed 1-propanol and propionate in a ratio of 1:1 [34, 35]. In contrast, C. perfringens converted 1,2-PD to 1-propanol without concomitant production of propionate. In our genome-based pathway model, C. perfringens only possessed DhaT producing NAD+ and lacked NADH-generating PduP (Fig. 4). Lactate production was highest during growth in YC-G50, and lower lactate production in the presence of both glucose and 1,2PD may be associated with DhaT activity, which used NADH as electron donor instead of lactate dehydrogenase Ldh (Fig. 4). Similarly A. hallii produced more 1-propanol (and not propionate) when grown in the presence of 1,2PD and glucose, compared to 1,2PD alone [28] suggesting that A. hallii also regenerated NAD+ pool through activity of PduQ.
Fig. 4
Genome based pathway reconstruction supported by gene expression analysis and metabolite data. Suggested schemes of metabolic pathways in the presence of 1,2PD and glucose in C. perfringens FMT 1006. Stars indicate proposed NAD+/NADH pools for metabolisms examined during this study. Orange dashed arrow indicates the proposed metabolism shift when 1,2PD and glucose are supplied simultaneously in C. perfringens FMT 1006
Bild vergrößern
To investigate further whether 1-propanol formation depended on the concurrent formation of acetate and/or lactate, we evaluated the impact of addition of 1,2PD (50 mM) to cultures grown in YC-G50 at early exponential (3 h), late exponential (6 h) and during stationary growth phase (12 h). After 24 h growth, highest turbidity was achieved when 1,2PD was added at 3 h (10.6 ± 0.6 MF), followed by 12 h (9.4 ± 0.2 MF) and 6 h (7.5 ± 0.2 MF) (Fig. 3D). Turbidity recorded at 3 h before injection (3.4 ± 0.0 MF) was lower (p < 0.05) compared to 24 h (Fig. 3D). Consumption of glucose (19.6–23.6 mM) and 1,2PD (48.4–63.2 mM) was similar at all three conditions, suggesting that substrate utilisation was not affected by the concurrent presence of glucose and 1,2PD (Fig. 3E and F). These observations are in contrast to Clostridium beijerinckii or C. butylicum, whose Pdu metabolism was repressed when glucose was provided [36, 37].
When 1,2PD was added after 3 or 6 h, levels of acetate and lactate were similar, and the ratio of acetate: lactate was 0.6:1.0 compared to 2.9:1.0 at 12 h (Fig. 3E). When 1,2PD was added at 3 h, the recovery of C1,2PD used as Cpropanol+Cpropanal was 87% with 35.9 ± 3.0 mM 1-propanol and 19.3 ± 4.7 mM propanal produced (Fig. 3F). At 6 and 12 h, the recovery of C1,2PD used as Cpropanol+Cpropanal was lower (57% and 29%, respectively) (Fig. 3F). Conversion to 1-propanol was higher (p < 0.05) when 1,2PD was added during exponential growth compared to stationary phase.
These differences in recovery of 1,2PD metabolites again suggest that the conversion of pyruvate to acetate or lactate plays a role in the production of 1-propanol. In the presence of glucose, acetate formation can deliver ATP (Fig. 4), and when pyruvate is transformed to acetate, there is less lactate formed, and NADH consumed which can provide NADH to PduQ (Fig. 4). In infant feces, C. perfringens likely has access to both glucose and 1,2PD. In agreement, 1-propanol was recovered in 54-63% of fecal samples of breastfed infants that were collected between 2 weeks and 2 months of life [38, 39]. 1-propanol was detected in feces of breastfed infants as early as eight days after birth [39], in agreement with early colonisation by Clostridium spp. [40]. While C. perfringens might not be able to contribute to the intestinal propionate pool through 1,2PD cross-feeding, it can provide 1-propanol to the gut intestinal environment.

1,2PD had little impact on membrane fluidity of C. perfringens

At the provided cultivation conditions, C. perfringens FMT 1006 growth was not supported by the presence of 1,2PD. As an alcohol, 1,2PD could increase in membrane fluidity, leading to leakage of cofactors and even a collapse of metabolic activity [41]. Ethanol and butanol have been shown to decrease proton flux across the membrane, to alter ATPase activity and to reduce energy production [41]. Therefore, we investigated the effect of 1,2PD on the state of the membrane using the stain Laurdan (1-(6-(dimethylamino)naphthalen-2-yl)dodecan-1-one). Due to its apolarity, Laurdan can dissolve within the lipidic membrane, shifting emission spectra from 440 nm (gel-phase) to 490 nm (liquid-phase). We used phenylethanol (PE) (10 and 50 mM) as positive control as PE increases fluidity [42], and tested 1,2PD (10 and 50 mM) and the pathway intermediate propanal (20 and 50 mM).
Addition of PE significantly increased (p < 0.05) membrane fluidity in a dose-dependent manner compared to cells that were not treated as indicated by a lower Generalised Polarisation (GP) value. In comparison, 1,2PD increased membrane fluidity less than 0.9-fold when added at 50 mM, and reduced membrane fluidity by ∆GP 1.05 at 10 mM (Fig. 5A). The aldehyde propanal did not affect overall membrane fluidity. Huffer et al. [41] assessed the effect of different alcohols on bacterial membranes, and concluded that strains whose membrane fluidity did not change significantly were more tolerant towards alcohol exposure. These tolerant strains included C. beijerinckii [41]. As there was only a slight effect on membrane fluidity even at a concentration of 50 mM, our results point out that the C. perfringens FMT 1006 membrane was tolerant towards exposure to 1,2PD at levels that might be similar as observed in vivo [2, 6].
Fig. 5
Impact of 1,2PD on the membrane fluidity and composition of C. perfringens. The impact of 1,2PD on membrane fluidity was determined using Laurdan while composition of membrane lipids after incubation in YC, YC-G50 and YC-PD50 for 24 h at 37 °C was analysed using LC-MS/MS. (A) Effect of 1,2PD on general polarisation (GP) of the membrane. Shown are the differences in GP levels in treatment versus the control (PBS only). Experiments were conducted in biological triplicates. (B) Peak intensities of major membrane lipid components. Shown are mean values of biological duplicates. (C) Log2 fold change of lipids in YC-PD50 (50 mM) compared to YC-G50 (50 mM) obtained from DESeq analysis in C. perfringens FMT 1006 cultured in YC-G50 (50 mM) or YC-PD50 (50 mM). Different letters denote significant difference between conditions (p < 0.05, Dunn’s Test adjusted by Holm). Significance by Wald test (p < 0.05) is indicated with (*). PE: Phenylethanol. PD: 1,2-propanediol. Diacylglycerols (DAG), monoacylglycerols (MAG), glycerophosphoethanolamines (GPE) and triacyclglycerols (TAG)
Bild vergrößern

Incubation in the presence of 1,2PD altered composition of a fraction of membrane lipids

Exposure to alcohols might not only affect membrane fluidity but can also cause alterations in lipid composition. We therefore evaluated membrane composition of C. perfringens FMT 1006 after 24 h incubation in YC-PD50, YC and YC-G50. We extracted the lipidic fraction using the SIMPLEX protocol [43] and determined lipid composition with liquid chromatography–tandem mass spectrometry (LC-MS/MS). For data extraction, peak identification and normalisation we used MS-DIAL [44] and further analysed the results with RStudio.
Membrane lipids were mainly composed of diacylglycerols (DAG), monoacylglycerols (MAG), triacyclglycerols (TAG), and glycerophosphoethanolamines (GPE) (Fig. 5B). During growth in YC-G50, the most abundant lipids were DAG (33%), TAG (36%) and GPE (30%). When cultured in YC and YC-PD50, the proportion of GPE (10% and 8%) was lower compared to YC-G50, while the proportions of TAG (54% and 38%) and DAG (36% and 52%) were higher (Fig. 5B). There was little difference in the composition of the MAG and DAG fractions when C. perfringens was incubated in YC-G50 or YC-PD50 (data not shown). In contrast, the composition of GPE lipids, which are major components of the lipidic membranes of gram positive bacteria [45], differed (Fig. 5C).
There were little difference in the composition of the MAG and DAG fractions when incubated in YC-G50 and YC-PD50 (data not shown) while the composition of GPE lipids shifted (Fig. 5C). The membrane of C. perfringens FMT 1006 had a higher abundance of shorter GPE when cultured in YC-G50 compared to YC-PD50 (Fig. 5C) suggesting a more pronounced membrane rigidification due to the presence of 1,2PD (Fig. 5C) [45].
As we observed changes in membrane lipid composition, we investigated expression of genes of the fatty acid biosynthesis cluster fab, which has been linked to membrane lipid modification during stress conditions in Bacillus and Clostridium sp [46, 47]. Based on microarray data, expression levels of fab related genes did not significantly differ between growth in YC-PD50 compared to YC or YC-G50 (Suppl. Table S3).

Conclusion

Composition of the intestinal microbiota of infants and its fermentation activity is increasingly recognised as contributor to health outcome in later life, yet the role of the alcohol 1,2PD during breastfeeding has been little studied. Our results suggest that C. perfringens is a utiliser of 1,2PD that can contribute to intestinal 1-propanol formation during breastfeeding. The presence of 1,2PD altered composition of certain membrane lipids and caused little changes of membrane fluidity, which might indicate a certain level of tolerance of C. perfringens towards 1,2PD. These findings advance our understanding of the interactions of intestinal metabolites and microbes during breastfeeding. Currently, few strains of C. perfringens have been isolated from infant feces and characterized in regard to 1,2PD utilisation; investigations on further strains will indicate the potential to generalise findings made for FMT 1006.

Materials and methods

Culture media and incubation conditions

Materials were purchased from Merck unless stated otherwise. C. perfringens FMT 1006 was obtained from the strain collection of the group of Functional Microbe Technology (FMT) (Aarhus University, Denmark) and was originally isolated from infant feces [17]. FMT 1006 was routinely cultivated in Wilkins-Chalgren medium supplemented with 5 g/L soya peptone (WCSP, Thermo Fisher), 1 g/L Tween 80, and 0.5 g/L L-cysteine-HCl. The pH was adjusted to 7.1 before boiling, and L-cysteine-HCl was added before degassing for a final pH of 6.5 after autoclaving. Samples were dispersed in serum flasks (30 mL) or Hungate tubes (10 mL) under constant CO2 flow, closed and autoclaved at 120 °C for 20 min. For initiation of working cultures, cells were streaked from frozen stocks on anaerobically prepared WCSP agar plates (WSCP with the addition of 15 g/L agar (VWR)) in an anaerobic chamber (10% CO2, 5% H2, 85% N2, Baker Ruskinn) and were incubated at 37 °C for 24 h.
Colonies were transferred to a 10 mL Hungate tube containing anaerobically prepared, modified yeast extract-casitone (YC) medium as described by Huertas-Díaz et al. [2]. supplied with 50 mM glucose (YC-G50). After two transfers in YC-G50, cultures were used in the assays. Strain purity was routinely checked using bright field microscopy.
To determine growth behaviour and to collect samples for RNA isolation and analysis of membrane lipids, working cultures were inoculated (2%) in YC in serum flasks in YC, YC-G50 and, YC-PD50. Growth was monitored as optical density at 600 nm (OD600) using a cell densitometer (Ultrospec 10, Biochrom). When incubated with glucose, C. perfringens showed regular growth behaviour with a lag phase, exponential and stationary growth phase, while during incubation in YC and YC-PD50, there was only a minor increase in turbidity at around 3–4 h. We therefore collected cell pellets of cultures grown in YC-G50 at early-stage growth phase (0.2 OD600), for isolation of RNA. Samples for RNA profiling of YC and YC-PD50 were obtained when the OD600 increased from 0.14 to 0.20 and from 0.16 to 0.30 after 3 and 4 h incubation, respectively. Cell pellets were snap frozen in liquid nitrogen and placed at − 80 °C until further processing. All experimental work was performed in independent biological replicates (n = 2–7). Cell pellets were collected from the remaining biomass after 24 h incubation for determination of the composition of membrane lipids and stored at − 80 °C.
To test for the impact of glucose on 1,2PD metabolism, working cultures were inoculated (2%) in Hungate tubes containing YC-G50, YC, YC-PD10, YC-PD10-G10, YC-PD50, YC-PD50-G50. Additionally, we investigated how 1,2PD addition affected the fermentation activity of C. perfringens grown in YC-G50 and added 1,2PD after 3, 6 and 12 h of incubation. Turbidity was measured prior addition of 1,2PD and after 24 h incubation. Growth rate in YC-G50 was calculated at 6 h of growth as 1/(duration of incubation * ln [2]) / ln (OD600/initial OD600).

DNA isolation and genome analysis

DNA was extracted from working cultures following the instructions from manufacturer (Genomic DNA purification kit GeneJET, Thermo Scientific for Gram-positive bacteria). Purified DNA was suspended in 40 µL of TE buffer. Libraries were prepared and sequenced using MiSeq (Department of Biology, Aarhus University) and Oxford Nanopore Technologies (Plasmidosaurus) and standard library preparation protocols. For quality filtering and assembly, the following process was used: FitLong (v0.2.1) was used to remove 5% of the lowest quality reads and to reduce the reads to 250 Mb [48]. A rough assembly was created with Miniasm (v0.3) which reduced to 100× coverage [49]. Flye (v2.9.1) assembly was run with parameters selected for high quality ONT reads [50] and Medaka (v1.8.0) was used to refine the Flye assembly [51]. Contig analysis was performed using Bandage (v0.8.1), quality check and contamination was assessed by CheckM (v1.2.2) [52, 53]. The assembly was refined using Polypolish (v0.5.0) with the Illumina reads previously trimmed with Trimmomatic (v0.39) and quality checked with FastQC (v0.11.9) [5456]. Annotations were done with Prokka (v1.14.5) [20] and InterProScan (v5.60-92.0) was used for annotation refinements [21]. Metabolic pathways were assessed with KofamKOALA (v2024.02.01) [57]. Annotations were evaluated using Artemis software (v18.2.0) [58]. Additional BLASTp was performed with selected Pdu proteins of FMT 1006 against the NCBI using the database (non-redundant protein sequences). For comparative genome analysis of C. perfringens FMT 1006 and the complete genomes of six other strains of C. perfringens (Table 1), EDGAR3.0 was used [19] to determine the core genome ANI values based on all-against-all comparisons [18, 19].

RNA extraction and cDNA labelling

To isolated RNA, we followed TRizol procedure. TRizol (1 mL) was added to the pellets and incubated at room temperature for 5 min. Chloroform (0.2 mL) was added, mixed by shaking, and the sample was incubated for 3 min, followed by centrifugation for 15 min at 12 000 × g at 4 °C. The aqueous phase was transferred into a new 1.5 mL tube and mixed with an equal volume of 70% ethanol. The sample was transferred to a RNeasy spin column and processed according to the manufacturer’s instruction (RNeasy Mini Kit, Qiagen). Chromosomal DNA was removed using the TURBO DNA-free™ Kit (Thermo Fisher) and the absence of DNA was confirmed using quantitative PCR (qPCR) with primers targeting the 16 S rRNA gene as described [59]. A total of 10 µg of RNA were simultaneously reverse transcribed and labelled using 7 µg of 5′ Cy3 random nonamer (Biomers) as previously described [30]. Briefly, the mixture was diluted in nuclease free water and incubated for 70 °C for 5 min and placed immediately on ice. For reverse transcription, a mixture of 6 µL of 5X first strand buffer, 1.5 µL of 0.1 M DTT, 1 µL of 10 mM dNTP, 4 µL of Superscript 3 (200 U/µL, Thermo Fisher) and 1 µL of RNase out (40 U/µL, Thermo Fisher) was added to the previous mixture and incubated for 5 mi at 25 °C followed by 3 h at 42 °C. For hydrolysis, a mixture of 16 µL of 200 mM NaOH and 16 µL of 20 mM of EDTA were added to the mixture and incubated for 10 min at 65 °C. For the neutralisation step, 64 µL of 1 M HEPES (pH 7) was added to the previous mixture. For purification, QiaQuick PCR purification kit was used according to instructions.

Microarray hybridisation and quantitative PCR

Probes for the C. perfringens were designed using OligoPicker software [60] with default settings. For microarray design a total of 2618 unique oligo sets out of total 2771 genes. Each gene was represented for an average of 2.5 different probes of 70mer length. A 4-part chamber array design was used with 35.000 spots from which each probe would be represented approximately 5 times and each gene 12.5 times. 60 probes were added with ‘QC 25mer’ as an internal quality control and 10 empty sequences for background subtraction. For gene expression analysis, 0.125 µg of Cy3-labelled cDNA were used per chamber in a 4-part array. Data extraction was performed using NimbleScan 2.1 (Roche-NimbleGen), employing robust multichip analysis for inter-array normalization purposes. All experiments were performed in biological and technical duplicates. Data normalisation was performed using robust multichip analysis (RMA) method followed by quality control of QC25 k-mers [61]. Background probes were added to all parts of microarray and background was subtracted after normalisation. For final data comparison, DESeq2 analysis was used [62]. Further information is provided in supplementary methods. qPCR was performed to determine relative expression levels of major genes of pdu as described in the supplementary methods [59].

Membrane fluidity assay

To investigate changes in the fluidity of the cell membrane, a Laurdan staining method was adapted taking into account the requirements for anaerobic conditions of FMT 1006. All procedures were performed in an anaerobic chamber and all chemicals and materials were pre-heated to 37 °C to avoid membrane-associated thermal changes. Laurdan stock (1 mM) in acetone was kept at -20 °C.
Samples (0.5 mL) were withdrawn from a 24 h culture in YC-G50 and mixed with PBS buffer (pH 7.4) to a final density of 0.5 OD600. The cell pellet was washed with phosphate buffered saline (PBS) twice at 10,000 × g for 30 s. Samples were resuspended in PBS containing 50 mM 1,2PD (PD50), 10 mM 1,2PD (PD10), 50 mM PE, 50PE, 10 mM PE (10PE), 50 mM propanal, 20 mM propanal, or PBS only as negative control together with Laurdan (10 µM). Samples were incubated for 30 min at 37 °C.
After incubation, cells were washed twice with PBS buffer and pellets were resuspended in the same treatment solutions without Laurdan. Cell suspensions (200 µL) were added to a 96-well black clear bottom plate and fluorescent intensity was determined using a fluorescence microplate reader (CLARIOstart Plus, BMG LABTECH) at excitation 350 nm and emission 380 nm to 600 nm at 37 °C. The experiment was repeated three times, and each sample was analysed in technical duplicates.
The Generalised Polarisation (GP) values were calculated using fluorescent emission intensity values at 440 nm and 490 nm as follows: GP=(I440-I490)/(I440 + I490).

Determination of changes in membrane composition

To extract membrane lipids, we followed the SIMPLEX method for lipidomics as described [43] followed by LC-MS/MS for identification. Eluent A was prepared with MeOH/ACN/H2O (1:1:3), 5 mM ammonium acetate, 10 nM EDTA. Eluent B contained isopropanol with ammonium acetate (5 mM) and EDTA (10 nM). A 2 µL injection under a flow rate of 200 µL/min. Using a column Kinetex 1.7 μm C18 100 Å size 100 × 2.1 mm. Instrument control and data processing software was performed by Analyst (TF 1.7.1). Data processing was performed using MS Dial for lipidomics. Only proton adduct was analysed by MSDial [44]. Data was extracted after normalisation and analyzed by DESeq2 package in R. Analysis performed from biological duplicates. Further information in Supplementary materials and methods.

Substrate, metabolite and gas analysis

Substrate levels and fermentation metabolites present in supernatants were analysed by high performance liquid chromatography coupled to a refractive index detector (HPLC-RI) using a 1260 Infinity II LC System (all Agilent). Compounds were separated using a Hi-Plex H column (300 × 7.7 mm) attached to a guard (50 × 7.7 mm) column. The samples (10 µL injection volume) were eluted with 5 mM H2SO4 at a flow rate of 0.6 mL/min at 40 °C. Fermentation metabolites were quantified using external standards.
PTR-TOF-MS measurements were performed as previously reported [63]. The system was operated with H3O+ as the primary ion using the proton affinity to detect compounds by direct time-of-flight mass spectrometry [63]. Settings were 2.4 mbar, voltage 600 V and a temperature 80 C for an E/N of 140 Td The can mode ranged from m/z 5 to 200 and the airflow was set to 400 mL/min After calculating of concentrations within the headspace, Henry’s law was applied to calculate equilibrium liquid concentrations [63]. In addition, headspace gas phase sampling was done on adsorbent tubes coupled to thermal-desorption gas chromatography with mass spectrometric detection (TDGCMS) to verify identification of unknowns. The method has been described in more detail before [64].

Statistics

DESeq2 analysis was used both for microarray analysis and for lipidomics comparison [62]. Significance was calculated by Wald test. For statistical analysis of turbidity, we employed Kruskal-Wallis test with posthoc Dunn’s test adjusted by Holm using the package ‘rstatix’ v.0.7.2. Figures were made with RStudio and posterior modifications by Adobe Acrobat Pro, Excel or PowerPoint.

Acknowledgements

Marie Lund Braad and Ian Marshall from the Section of Microbiology at Aarhus University are acknowledged for assistance with sequencing and genome analysis. The authors thank Arya Das and Santra Santosh from Leibniz Institute for Food Systems Biology, Freising, Germany for assistance of microarray analysis.

Declarations

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Download
Titel
Insights into the utilisation of 1,2-propanediol and interactions with the cell envelope of Clostridium perfringens
Verfasst von
Lucía Huertas-Díaz
Louise Guldager Vestergaard
Angeliki Marietou
Marta Irla
Jürgen Behr
Mark M. Somoza
Anders Feilberg
Clarissa Schwab
Publikationsdatum
01.12.2025
Verlag
BioMed Central
Erschienen in
Gut Pathogens / Ausgabe 1/2025
Elektronische ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-025-00689-1

Electronic supplementary material

Below is the link to the electronic supplementary material.
1.
Zurück zum Zitat Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut Microbiome during the first year of life. Cell Host Microbe. 2015;17(5):690–703.PubMedCrossRef
2.
Zurück zum Zitat Huertas-Díaz L, Kyhnau R, Ingribelli E, Neuzil-Bunesova V, Li Q, Sasaki M, et al. Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces. Gut Microbes. 2023;15(1):2241209.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Bunesova V, Lacroix C, Schwab C. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium Kashiwanohense. BMC Microbiol. 2016;16(1):248.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Lawson MAE, O’Neill IJ, Kujawska M, Gowrinadh Javvadi S, Wijeyesekera A, Flegg Z, et al. Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem. ISME J. 2020;14(2):635–48.PubMedCrossRef
5.
Zurück zum Zitat Tsukuda N, Yahagi K, Hara T, Watanabe Y, Matsumoto H, Mori H, et al. Key bacterial taxa and metabolic pathways affecting gut short-chain fatty acid profiles in early life. ISME J. 2021;15(9):2574–90.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Wang A, Diana A, Rahmannia S, Gibson RS, Houghton LA, Slupsky CM. Impact of milk secretor status on the fecal metabolome and microbiota of breastfed infants. Gut Microbes. 2023;15(2):2257273.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Prentice MB. Bacterial microcompartments and their role in pathogenicity. Curr Opin Microbiol. 2021;63:19–28.PubMedCrossRef
8.
Zurück zum Zitat Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29–41.PubMedCrossRef
9.
Zurück zum Zitat Cheng CC, Duar RM, Lin X, Perez-Munoz ME, Tollenaar S, Oh JH, et al. Ecological importance of Cross-Feeding of the intermediate metabolite 1,2-Propanediol between bacterial gut symbionts. Appl Environ Microbiol. 2020;86(11):e00190–20.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Zhang J, Lacroix C, Wortmann E, Ruscheweyh HJ, Sunagawa S, Sturla SJ, et al. Gut microbial beta-glucuronidase and Glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation. BMC Microbiol. 2019;19(1):99.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Appert O, Garcia AR, Frei R, Roduit C, Constancias F, Neuzil-Bunesova V, et al. Initial butyrate producers during infant gut microbiota development are endospore formers. Environ Microbiol. 2020;22(9):3909–21.PubMedCrossRef
12.
Zurück zum Zitat Schwab C. The development of human gut microbiota fermentation capacity during the first year of life. Microb Biotechnol. 2022;15(12):2865–74.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Myers GSA, Rasko DA, Cheung JK, Ravel J, Seshadri R, DeBoy RT, et al. Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res. 2006;16(8):1031–40.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Kiu R, Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microbes Infect. 2018;7(1):1–15.CrossRef
15.
Zurück zum Zitat Stark PL, Lee A. Clostridia isolated from the feces of infants during the first year of life. J Pediatr. 1982;100(3):362–5.PubMedCrossRef
16.
Zurück zum Zitat Tonooka T, Sakata S, Kitahara M, Hanai M, Ishizeki S, Takada M, et al. Detection and quantification of four species of the genus Clostridium in infant feces. Microbiol Immunol. 2005;49(11):987–92.PubMedCrossRef
17.
Zurück zum Zitat Ingribelli E, Modrackova N, Tejnecky V, Killer J, Schwab C, Neuzil-Bunesova V. Culture-dependent screening of endospore-forming clostridia in infant feces. BMC Microbiol. 2023;23(1):347.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Goris J, Konstantinidis KT, Klappenbach JA, Coenye T, Vandamme P, Tiedje JM. DNA–DNA hybridization values and their relationship to whole-genome sequence similarities. Int J Syst Evol Microbiol. 2007;57(1):81–91.PubMedCrossRef
19.
Zurück zum Zitat Dieckmann MA, Beyvers S, Nkouamedjo-Fankep RC, Hanel PHG, Jelonek L, Blom J, et al. EDGAR3.0: comparative genomics and phylogenomics on a scalable infrastructure. Nucleic Acids Res. 2021;49(W1):W185–92.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinforma Oxf Engl. 2014;30(14):2068–9.CrossRef
21.
Zurück zum Zitat Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, et al. InterProScan 5: genome-scale protein function classification. Bioinforma Oxf Engl. 2014;30(9):1236–40.CrossRef
22.
Zurück zum Zitat Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587–92.PubMedCrossRef
23.
Zurück zum Zitat Leal NA, Havemann GD, Bobik TA. PduP is a coenzyme-a-acylating propionaldehyde dehydrogenase associated with the polyhedral bodies involved in B12-dependent 1,2-propanediol degradation by Salmonella enterica serovar typhimurium LT2. Arch Microbiol. 2003;180(5):353–61.PubMedCrossRef
24.
Zurück zum Zitat Sriramulu DD, Liang M, Hernandez-Romero D, Raux-Deery E, Lünsdorf H, Parsons JB, et al. Lactobacillus reuteri DSM 20016 produces Cobalamin-Dependent diol dehydratase in metabolosomes and metabolizes 1,2-Propanediol by disproportionation. J Bacteriol. 2008;190(13):4559–67.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Zeng Z, Smid EJ, Boeren S, Notebaart RA, Abee T. Bacterial Microcompartment-Dependent 1,2-Propanediol Utilization Stimulates Anaerobic Growth of Listeria monocytogenes EGDe. Front Microbiol. [cited 2024 May 7] 2019;15;10. Available from: https://www.frontiersin.org/journals/microbiology/articles/https://doi.org/10.3389/fmicb.2019.02660/full
26.
Zurück zum Zitat Bobik TA, Havemann GD, Busch RJ, Williams DS, Aldrich HC. The propanediol utilization (pdu) Operon of Salmonella enterica serovar typhimurium LT2 includes genes necessary for formation of polyhedral organelles involved in coenzyme B12-Dependent 1,2-Propanediol degradation. J Bacteriol. 1999;181(19):5967–75.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Sampson EM, Bobik TA. Microcompartments for B12-dependent 1,2-propanediol degradation provide protection from DNA and cellular damage by a reactive metabolic intermediate. J Bacteriol. 2008;190(8):2966–71.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Engels C, Ruscheweyh HJ, Beerenwinkel N, Lacroix C, Schwab C. The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate Formation. Front Microbiol. [cited 2024 Apr 29] 2016;19:7. Available from: https://www.frontiersin.org/journals/microbiology/articles/https://doi.org/10.3389/fmicb.2016.00713/full
29.
Zurück zum Zitat Behr J, Michel T, Giridhar M, Santhosh S, Das A, Sabzalipoor H et al. An open-source advanced maskless synthesizer for light-directed chemical synthesis of large nucleic acid libraries and microarrays. ChemRxiv; 2024 [cited 2024 Aug 22]. Available from: https://chemrxiv.org/engage/chemrxiv/article-details/65ba15e39138d231611ab534
30.
Zurück zum Zitat Das A, Santhosh S, Giridhar M, Behr J, Michel T, Schaudy E, et al. Dipodal silanes greatly stabilize glass surface functionalization for DNA microarray synthesis and High-Throughput biological assays. Anal Chem. 2023;95(41):15384–93.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Lietard J, Leger A, Erlich Y, Sadowski N, Timp W, Somoza MM. Chemical and photochemical error rates in light-directed synthesis of complex DNA libraries. Nucleic Acids Res. 2021;49(12):6687–701.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Cheng S, Fan C, Sinha S, Bobik TA. The PduQ enzyme is an alcohol dehydrogenase used to recycle NAD + Internally within the Pdu microcompartment of Salmonella enterica. PLoS ONE. 2012;7(10):e47144.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Huseby DL, Roth JR. Evidence that a metabolic microcompartment contains and recycles private cofactor pools. J Bacteriol. 2013;195(12):2864–79.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Jeter RM. Cobalamin-dependent 1,2-propanediol utilization by Salmonella typhimurium. Microbiology. 1990;136(5):887–96.
35.
Zurück zum Zitat Obradors N, Badía J, Baldomà L, Aguilar J. Anaerobic metabolism of the L-rhamnose fermentation product 1,2-propanediol in Salmonella typhimurium. J Bacteriol. 1988;170(5):2159–62.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Forsberg CW, Donaldson L, Gibbins LN. Metabolism of rhamnose and other sugars by strains of Clostridium acetobutylicum and other Clostridium species. Can J Microbiol. 1987;33(1):21–6.CrossRef
37.
Zurück zum Zitat Diallo M, Simons AD, van der Wal H, Collas F, Houweling-Tan B, Kengen SWM, et al. l-Rhamnose metabolism in Clostridium beijerinckii strain DSM 6423. Appl Environ Microbiol. 2019;85(5):e02656–18.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Costello BDL, Ewen R, Ewer AK, Garner CE, Probert CSJ, Ratcliffe NM, et al. An analysis of volatiles in the headspace of the faeces of neonates. J Breath Res. 2008;2(3):037023.CrossRef
39.
Zurück zum Zitat Frau A, Lett L, Slater R, Young GR, Stewart CJ, Berrington J, et al. The stool volatile metabolome of Pre-Term babies. Molecules. 2021;26(11):3341.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Vlková E, Nevoral J, Jencikova B, Kopečný J, Godefrooij J, Trojanová I, et al. Detection of infant faecal bifidobacteria by enzymatic methods. J Microbiol Methods. 2005;60(3):365–73.PubMedCrossRef
41.
Zurück zum Zitat Huffer S, Clark ME, Ning JC, Blanch HW, Clark DS. Role of alcohols in growth, lipid composition, and membrane fluidity of yeasts, bacteria, and archaea ▿. Appl Environ Microbiol. 2011;77(18):6400–8.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Schwab C, Gänzle MG. Effect of membrane lateral pressure on the expression of fructosyltransferases in Lactobacillus reuteri. Syst Appl Microbiol. 2006;29(2):89–99.PubMedCrossRef
43.
Zurück zum Zitat Coman C, Solari FA, Hentschel A, Sickmann A, Zahedi RP, Ahrends R. Simultaneous metabolite, protein, lipid extraction (SIMPLEX): A combinatorial multimolecular omics approach for systems biology. Mol Cell Proteom MCP. 2016;15(4):1453–66.PubMed
44.
Zurück zum Zitat Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, et al. MS-DIAL: data-independent MS/MS Deconvolution for comprehensive metabolome analysis. Nat Methods. 2015;12(6):523–6.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Willdigg JR, Helmann JD. Mini review: bacterial membrane composition and its modulation in response to stress. Front Mol Biosci. 2021;8:634438.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Beek AT, Keijser BJF, Boorsma A, Zakrzewska A, Orij R, Smits GJ, et al. Transcriptome analysis of sorbic Acid-Stressed Bacillus subtilis reveals a nutrient limitation response and indicates plasma membrane remodeling. J Bacteriol. 2008;190(5):1751–61.PubMedCrossRef
47.
Zurück zum Zitat Zhu L, Cheng J, Luo B, Feng S, Lin J, Wang S, et al. Functions of the Clostridium Acetobutylicium FabF and FabZ proteins in unsaturated fatty acid biosynthesis. BMC Microbiol. 2009;9(1):119.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Wick R, rrwick/Filtlong. 2024 [cited 2024 Mar 7]. Available from: https://github.com/rrwick/Filtlong
49.
Zurück zum Zitat Li H. Minimap and miniasm: fast mapping and de Novo assembly for noisy long sequences. Bioinformatics. 2016;32(14):2103–10.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Kolmogorov M, Yuan J, Lin Y, Pevzner PA. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol. 2019;37(5):540–6.PubMedCrossRef
51.
Zurück zum Zitat nanoporetech/medaka. Oxford Nanopore Technologies; 2024 [cited 2024 Mar 7]. Available from: https://github.com/nanoporetech/medaka
52.
Zurück zum Zitat Wick RR, Schultz MB, Zobel J, Holt KE. Bandage: interactive visualization of de Novo genome assemblies. Bioinformatics. 2015;31(20):3350–2.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Parks DH, Imelfort M, Skennerton CT, Hugenholtz P, Tyson GW. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. 2015;25(7):1043–55.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Wick R, rrwick/Polypolish. 2024 [cited 2024 Mar 7]. Available from: https://github.com/rrwick/Polypolish
55.
Zurück zum Zitat Andrews S. s-andrews/FastQC. 2024 [cited 2024 Mar 7]. Available from: https://github.com/s-andrews/FastQC
56.
Zurück zum Zitat Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114–20.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Aramaki T, Blanc-Mathieu R, Endo H, Ohkubo K, Kanehisa M, Goto S, et al. KofamKOALA: KEGG ortholog assignment based on profile HMM and adaptive score threshold. Bioinformatics. 2020;36(7):2251–2.PubMedCrossRef
58.
Zurück zum Zitat Carver T, Harris SR, Berriman M, Parkhill J, McQuillan JA. Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data. Bioinformatics. 2012;28(4):464–9.PubMedCrossRef
59.
Zurück zum Zitat Høgsgaard K, Vidal NP, Marietou A, Fiehn OG, Li Q, Bechtner J, et al. Fucose modifies short chain fatty acid and H2S formation through alterations of microbial cross-feeding activities. FEMS Microbiol Ecol. 2023;99(10):fiad107.PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Wang X, Seed B. Selection of oligonucleotide probes for protein coding sequences. Bioinformatics. 2003;19(7):796–802.PubMedCrossRef
61.
Zurück zum Zitat Brettschneider J, Collin F, Bolstad BM, Speed TP. Quality assessment for short oligonucleotide microarray data. Technometrics. 2008;50(3):241–64.CrossRef
62.
Zurück zum Zitat Zhu A, Ibrahim JG, Love MI. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinforma Oxf Engl. 2019;35(12):2084–92.CrossRef
63.
Zurück zum Zitat Pedersen J, Nyord T, Hansen MJ, Feilberg A. Emissions of NMVOC and H2S from field-applied manure measured by PTR-TOF-MS and wind tunnels. Sci Total Environ. 2021;767:144175.PubMedCrossRef
64.
Zurück zum Zitat Hansen MJ, Liu D, Guldberg LB, Feilberg A. Application of Proton-Transfer-Reaction mass spectrometry to the assessment of odorant removal in a biological air cleaner for pig production. J Agric Food Chem. 2012;60(10):2599–606.PubMedCrossRef
65.
Zurück zum Zitat Shimizu T, Ohtani K, Hirakawa H, Ohshima K, Yamashita A, Shiba T, et al. Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc Natl Acad Sci U S A. 2002;99(2):996–1001.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Mehdizadeh Gohari I, Kropinski AM, Weese SJ, Parreira VR, Whitehead AE, Boerlin P, et al. Plasmid characterization and chromosome analysis of two netF + Clostridium perfringens isolates associated with foal and canine necrotizing enteritis. PLoS ONE. 2016;11(2):e0148344.PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Abdel-Glil MY, Thomas P, Linde J, Busch A, Wieler LH, Neubauer H, et al. Comparative in Silico genome analysis of Clostridium perfringens unravels stable phylogroups with different genome characteristics and pathogenic potential. Sci Rep. 2021;11:6756.PubMedPubMedCentralCrossRef

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Lipoprotein(a) erhöht bei Statintherapie: Wie steht es um das kardiovaskuläre Risiko?

Wann ist das Lipoprotein(a) zu hoch? Diese Frage stellte sich ein deutsches Forschungsteam – und analysierte die Risiken durch Lp(a) bei Patienten, die bereits Statine einnehmen.

Adipositas und Vorhofflimmern: Wie hängen sie zusammen?

Adipositas begünstigt die Entstehung von Vorhofflimmern. Die Frage ist, inwieweit dabei direkte oder indirekte, über Begleiterkrankungen vermittelte Effekte im Spiel sind. In einer beim DGK-Kongress vorgestellten Studie wurde versucht, das zu klären.

Mehr als eine Hydrozele

Starke Schmerzen im rechten Hoden führen einen 37-jährigen Mann in die urologische Praxis. An ein Trauma kann sich der Fitnesstrainer nicht erinnern. Es gibt auch keine Hinweise auf eine Harnwegsinfektion, Harnsteine oder eine sexuell übertragbare Erkrankung. Was ist Ihre Verdachtsdiagnose?

Podcast

Warum wir mehr Peritonealdialysen durchführen sollten

Die Peritonealdialyse wird in Deutschland noch selten genutzt, bietet aber unterschätzte Vorteile: mehr Selbstbestimmung, mehr Lebensqualität, schonender für den Kreislauf. Warum wird sie trotzdem so wenig eingesetzt? Expertin Dr. Grit Esser erklärt, was hinter der Bauchfelldialyse steckt, wie Betroffene informierte Entscheidungen treffen können und worauf Hausärztinnen und Hausärzte achten sollten.

Zeitschrift für Allgemeinmedizin, DEGAM

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Ärztin misst Blutdruck bei adipöser Frau/© DG PhotoStock / stock.adobe.com (Symbolbild mit Fotomodellen), Hoden an einem Schaubild /© Mathias Ernert/ Urologische Klinik/ Universitätsklinikum Mannheim (Symbolbild mit Fotomodellen), ZFA TALKS - Peritonealdialyse/© (M) Jakovo / Getty Images / iStock (Symbolbild mit Fotomodell) Logo: Springer Medizin Verlag GmbH